FOXO TECHNOLOGIES INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage
FOXO TECHNOLOGIES INC. (FOXO) had Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage of 100.00% as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage · last filed 2021-05-17
- 2021-03-31: Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage 100.00%.
- 2020-12-31: Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage 100.00%.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage |
|---|---|
| 2021-03-31 | 100.00% 10-Q · filed 2021-05-17 |
| 2020-12-31 | 100.00% 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |